CK Life Sciences International Holdings has a quick ratio of 0.51. It indicates that the company cannot currently fully pay back its current liabilities.
STU:LSI's Quick Ratio is ranked worse than 89.56% of 1417
companies
in the Biotechnology industry
Industry Median: 3.6
vs STU:LSI: 0.51
CK Life Sciences International Holdings (STU:LSI) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
CK Life Sciences International Holdings Quick Ratio Related Terms
CK Life Sciences International Holdings Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CK Life Sciences International Holdings Quick Ratio Chart
CK Life Sciences International Holdings Annual Data
STU:LSI vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, CK Life Sciences International Holdings's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CK Life Sciences International Holdings Quick Ratio vs Biotechnology Industry
CK Life Sciences International Holdings Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CK Life Sciences International Holdings (STU:LSI) has a Quick Ratio of 0.51 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on CK Life Sciences International Holdings and its competitors. This is 38% below median its historical median of 0.82. Over the past decade, CK Life Sciences International Holdings' Quick Ratio has ranged from 0.45 to 2.10. According to the industry distribution chart, CK Life Sciences International Holdings ranks #1269 out of 1417 companies in the Biotechnology industry, placing it in the top 89.6%.
Is CK Life Sciences International Holdings' Quick Ratio too high?
CK Life Sciences International Holdings' current Quick Ratio of 0.51 is 38% below median its 10-year median of 0.82. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 2.10. The Biotechnology industry median Quick Ratio is 3.60. CK Life Sciences International Holdings' value of 0.51 is 85.8% below this industry median. Based on the distribution chart, CK Life Sciences International Holdings ranks #1269 out of 1417 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CK Life Sciences International Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does CK Life Sciences International Holdings' Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CK Life Sciences International Holdings ranks #1269 out of 1417 companies for Quick Ratio. This places CK Life Sciences International Holdings in the lower half of its industry. The industry median Quick Ratio is 3.60. CK Life Sciences International Holdings' value of 0.51 is 85.8% below this benchmark. Historically, CK Life Sciences International Holdings' own Quick Ratio has ranged from 0.45 to 2.10 over the past decade. While the company's 10-year median is 0.82 vs. the industry median of 3.60, CK Life Sciences International Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,417 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CK Life Sciences International Holdings's current Quick Ratio of 0.51 is 85.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on CK Life Sciences International Holdings and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CK Life Sciences International Holdings's current Quick Ratio is 0.51, which is 38% below median its own 10-year median of 0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CK Life Sciences International Holdings stock overvalued right now?
CK Life Sciences International Holdings (STU:LSI) has a current Quick Ratio of 0.51. The stock's GF Value™ is €0.08, compared to a current price of €0.07 — trading 17.5% below its estimated fair value. The current Quick Ratio is 0.51, which is 38% below median its 10-year median of 0.82 and 85.8% below the Biotechnology industry median of 3.60. CK Life Sciences International Holdings' overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For CK Life Sciences International Holdings (STU:LSI), the current Quick Ratio is 0.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CK Life Sciences International Holdings (STU:LSI) Overvalued in 2026?
Based on GuruFocus' analysis, CK Life Sciences International Holdings stock appears to be undervalued.
The current stock price of €0.07 is trading 17.5% below its estimated GF Value™ of €0.08.
Key valuation signals for STU:LSI:
Quick Ratio: 0.51 (38% below median its 10-year median of 0.82)
GF Value™: €0.08 vs. price of €0.07 (17.5% below fair value)
Industry Position: 85.8% below the Biotechnology median (#1269 of 1417)
No single metric tells the full story. See the STU:LSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CK Life Sciences International Holdings Business Description
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
34GF Score
Get the complete analysis for STU:LSI
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:LSI has been successfully added to your 
